more results of drug trials, i have a minimum price target of...

more results of drug trials, i have a minimum price target of 10cents on completion of successful human trials , with a short term tgt of 5-6 cents if they have continuing success with drud trials. Some of the drugs they are testing sell in the billions p.anum. Of course that doesn't translate to immediate success for obj, however if these drugs are either in mature stage of lifecylcle or off patent, a new delivery platform may be the answer. remember that obj only changes the bodies ability to absorb a drug and does nothing to the drug itself. Acrux modifies the drug to enable it to be blasted through the skin and so has to reapply for regulatory approval. They don't expect to be on the mkt till 2008. OBJ could be in pharmacies much quicker.
At 10c mkt cap only 34m , ACR 100m